Trending Now
Category: Press Releases
A Curia apoia o ensaio clínico de fase 1 da nova vacina de RNA de última geração da Replicate Bioscience
September 13, 2023
O fornecimento de um fármaco fabricado segundo as normas de BPFa apoia o primeiro estudo clínico em seres humanos do
Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA Vaccine
September 13, 2023
Supply of drug substance manufactured under cGMP supports first-in-human clinical study for RBI-4000 novel self-replicating RNA (srRNA) ALBANY, N.Y., Sept.
Curia soutient l’essai clinique de phase 1 de Replicate Bioscience sur un vaccin novateur à base d’ARN de nouvelle génération
September 13, 2023
L’entreprise apporte une substance médicamenteuse fabriquée selon les BPFa afin de permettre la première étude clinique chez un être humain
Annual Investment Meeting announces new identity as AIM Congress, gears up for 13th edition in Abu Dhabi, May 2024
September 13, 2023
ABU DHABI, United Arab Emirates, Sept. 13, 2023 (GLOBE NEWSWIRE) — Under its new identity as “AIM Congress,” the Organizing
Deriv Group to launch Deriv Prime at IFX EXPO Cyprus 2023
September 13, 2023
Deriv Prime – Liquidity solution provider LIMASSOL, Cyprus, Sept. 13, 2023 (GLOBE NEWSWIRE) — Deriv Group has announced that it
Deriv Group lancera Deriv Prime lors du IFX EXPO Cyprus 2023
September 13, 2023
Deriv Prime – Les solutions de liquidité LIMASSOL, Chypre, 13 sept. 2023 (GLOBE NEWSWIRE) — Deriv Group a annoncé le
